1
|
Scheffer GL, Maliepaard M, Pijnenborg AC,
et al: Breast cancer resistance protein is localized at the plasma
membrane in mitoxantrone- and topotecan-resistant cell lines.
Cancer Res. 60:2589–2593. 2000.PubMed/NCBI
|
2
|
Kuo MT: Roles of multidrug resistance
genes in breast cancer chemoresistance. Adv Exp Med Biol.
608:23–30. 2007. View Article : Google Scholar : PubMed/NCBI
|
3
|
Guo X, Ma N, Wang J, Song J, Bu X, Cheng
Y, et al: Increased p38-MAPK is responsible for chemotherapy
resistance in human gastric cancer cells. BMC Cancer. 8:3752008.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Honma K, Iwao-Koizumi K, Takeshita F,
Yamamoto Y, Yoshida T, Nishio K, et al: RPN2 gene confers docetaxel
resistance in breast cancer. Nat Med. 14:939–948. 2008. View Article : Google Scholar : PubMed/NCBI
|
5
|
Katoh SY, Ueno M and Takakura N:
Involvement of MDR1 function in proliferation of tumour cells. J
Biochem. 143:517–524. 2008. View Article : Google Scholar : PubMed/NCBI
|
6
|
Chen Z, Liu F, Ren Q, Zhao Q, Ren H, Lu S,
et al: Suppression of ABCG2 inhibits cancer cell proliferation. Int
J Cancer. 126:841–851. 2010.PubMed/NCBI
|
7
|
Nakagawa M, Schneider E, Dixon KH, Horton
J, Kelley K, Morrow C and Cowan KH: Reduced intracellular drug
accumulation in the absence of P-Glycoprotein (mdr1) overexpression
in mitoxantrone-resistant human MCF-7 breast cancer cells. Cancer
Res. 52:6175–6181. 1992.PubMed/NCBI
|
8
|
Wakabayashi K, Nakagawa H, Adachi T, Kii
I, Kobatake E, Kudo A and Ishikawa T: Identification of cysteine
residues critically involved in homodimer formation and protein
expression of human ATP-binding cassette transporter ABCG2: a new
approach using the flp recombinase system. J Exp Ther Oncol.
5:205–222. 2006.
|
9
|
Saito H, Hirano H, Nakagawa H, Fukami T,
Oosumi K, Murakami K, et al: A new strategy of high-speed screening
and quantitative structure-activity relationship analysis to
evaluate human ATP-binding cassette transporter ABCG2-drug
interactions. J Pharmacol Exp Ther. 317:1114–1124. 2006. View Article : Google Scholar
|
10
|
Wang T, Kajino K, Abe M, Tan K, Maruo M,
Sun G, et al: Suppression of cell death by the secretory form of
N-terminal ERC/mesothelin. Int J Mol Med. 26:185–191.
2010.PubMed/NCBI
|
11
|
Fujimura T, Shinohara Y, Tissot B, Pang
PC, Kurogochi M, Saito S, et al: Glycosylation status of
haptoglobin in sera of patients with prostate cancer vs. benign
prostate disease of normal subjects. Int J Cancer. 122:39–49. 2008.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Janicke RU, Sprengart ML, Wati MR and
Porter AG: Caspase-3 is required for DNA fragmentation and
morphological changes associated with apoptosis. J Biol Chem.
273:9357–9360. 1998. View Article : Google Scholar : PubMed/NCBI
|
13
|
Wilkinson B and Gilbert HF: Protein
disulfide isomerase. Biochim Biophys Acta. 1699:35–44. 2004.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Keenan J, Murphy L, Henry M, Meleady P and
Clynes M: Proteomic analysis of multidrug-resistance mechanisms in
adriamycin-resistant variants of DLKP, a squamous lung cancer cell
line. Proteomics. 9:1556–1566. 2009. View Article : Google Scholar : PubMed/NCBI
|
15
|
Liu Y, Liu H, Han B and Zhang JT:
Identification of 14-3-3sigma as a contributor to drug resistance
in human breast cancer cells using functional proteomic analysis.
Cancer Res. 66:3248–3255. 2006. View Article : Google Scholar : PubMed/NCBI
|
16
|
Montano MM, Ekena K, Delage-Mourroux R,
Chang W, Martini P and Katzenellenbogen BS: An estrogen
receptor-selective coregulator that potentiates the effectiveness
of antiestrogens and represses the activity of estrogens. Proc Natl
Acad Sci USA. 96:6947–6952. 1999. View Article : Google Scholar : PubMed/NCBI
|
17
|
Zubovych I, Doundoulakis T, Harran PG and
Roth MG: A missense mutation in Caenorhabditis elegans
prohibitin 2 confers an atypical multidrug resistance. Proc Natl
Acad Sci USA. 103:15523–15528. 2006.PubMed/NCBI
|
18
|
Shau H and Kim A: Identification of
natural killer enhancing factor as a major antioxidant in human red
blood cells. Biochem Biophys Res Commun. 199:83–88. 1994.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Kowaltowski AJ, Netto LE and Vercesi AE:
The thiol-specific antioxidant enzyme prevents mitochondrial
permeability transition evidence for the participation of reactive
oxygen species in this mechanism. J Biol Chem. 273:12766–12769.
1998. View Article : Google Scholar
|
20
|
Chung YM, Yoo YD, Park JK, Kim YT and Kim
HJ: Increased expression of peroxiredoxin II confers resistance to
cisplatin. Anticancer Res. 21:1129–1133. 2001.PubMed/NCBI
|